Modulation of striatal dopamine release by 5-HT2A and 5-HT2C receptor antagonists: [11C]raclopride PET studies in the rat
- 3 July 2008
- journal article
- research article
- Published by Springer Science and Business Media LLC in Psychopharmacology
- Vol. 200 (4), 487-496
- https://doi.org/10.1007/s00213-008-1226-4
Abstract
No abstract availableThis publication has 65 references indexed in Scilit:
- Pharmacologic mechanisms of serotonergic regulation of dopamine neurotransmissionPharmacology & Therapeutics, 2007
- Physiological relevance of constitutive activity of 5-HT2A and 5-HT2C receptorsTrends in Pharmacological Sciences, 2005
- Modulation of dopamine release by striatal 5‐HT2C receptorsSynapse, 2005
- 5‐HT2A and α1b‐adrenergic receptors entirely mediate dopamine release, locomotor response and behavioural sensitization to opiates and psychostimulantsEuropean Journal of Neuroscience, 2004
- 5-HT2 receptors differentially modulate dopamine-mediated auto-inhibition in A9 and A10 midbrain areas of the ratNeuropharmacology, 2004
- Tyrosine‐free amino acid mixture attenuates amphetamine‐induced displacement of [11C]raclopride in striatum in vivo: A rat PET studySynapse, 2003
- Fenfluramine evokes 5-HT2A receptor-mediated responses but does not displace [11C]MDL 100907: Small animal PET and gene expression studiesSynapse, 2003
- The potential of high-resolution positron emission tomography to monitor striatal dopaminergic function in rat models of disease.Journal of Neuroscience Methods, 1996
- 5-Methyl-1-(3-pyridylcarbamoyl)-1,2,3,5-tetrahydropyrrolo[2,3-f]indole: A Novel 5-HT2C/5-HT2B Receptor Antagonist with Improved Affinity, Selectivity, and Oral ActivityJournal of Medicinal Chemistry, 1995
- Ketanserin pretreatment attenuates MDMA-induced dopamine release in the striatum as measured by in vivo microdialysisLife Sciences, 1990